Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Tightens Clinical Trial Oversight Post Gene-Edited Babies Scandal

Executive Summary

New draft regulation will require state-level approval over high-risk and reproductive use of gene and cell technologies.

You may also be interested in...

Chinese Scientist Behind Gene Edited Babies Gets 3 Year Jail Term

Scientific experiment now a criminal charge and the scientist He Jiankui is sentenced to three years in prison and also levied a fine.Two collaborators face similar fate.

Made In China Gene Therapy A Father's Quest To Save Son With UltraRare Condition

Patient-driven drug development meets the old saying of "where there's a will, there's a way" in China, potentially the world's largest market for rare disease treatments.

Deny, Denounce, Debate: China Gene-Edited Babies Awaken Genie In The Bottle

With the birth of the world's first gene-edited babies, Chinese researchers again step into the epicenter of a controversy between the use of cutting-edge technology and calls for the tightening of ethical oversight of such research.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts